Medtrum Germany Pump Launch
Medtrum launches higher-capacity 300U tubeless patch pump in Germany, enhancing patient access.
Anonymous
Medtrum has announced the German launch of its 300-unit (300U) tubeless patch pump, a device that holds 50% more insulin than standard 200-unit pumps, according to PR Newswire. The pump is part of the company's TouchCare Nano System and is designed to be worn directly on the body — no tubes required.
The 300U pump has been added to Germany's statutory health insurance medical aids directory under its own Hilfsmittelnummer — a product registration number that unlocks reimbursement through Germany's public health system, Newswire reported. That listing is a key step toward making the device accessible to a wide range of patients.
What Makes the 300U Pump Different From Standard Options
Most tubeless patch pumps hold 200 units of insulin. Medtrum's new 300U version holds 50% more. That extra capacity means fewer refills and less disruption for patients who need higher daily doses, according to PR Newswire. The pump sits directly on the skin and has no external tubing, making it more discreet than traditional insulin pump setups.
The device is part of Medtrum's TouchCare Nano System. Medtrum describes itself as a global diabetes technology company. The 300U pump expands the options available within that system, giving patients and doctors more flexibility when choosing an insulin delivery method, ADVFN reported.
Germany's Reimbursement System Opens the Door to Patients
Getting listed in Germany's Hilfsmittelverzeichnis — the statutory health insurance medical aids directory — is a major milestone. It means the pump now has an official product registration number, called a Hilfsmittelnummer. Without that number, patients cannot access reimbursement through Germany's public insurance system, according to Newswire.
Germany has one of Europe's largest statutory health insurance networks. Securing a place in its reimbursement directory gives Medtrum a direct path to millions of insured patients. ADVFN UK noted the listing supports Medtrum's push for broader patient access and sustainable growth across Europe.
Medtrum's Bigger Push Into the European Market
The 300U launch is part of a wider European expansion for Medtrum. Germany is one of the continent's most important medical device markets, and a successful rollout there can open doors to other countries. The company says the launch reflects its commitment to patient-centered treatment options, according to PR Newswire.
Tubeless patch pumps are a fast-growing segment of the insulin delivery market. They appeal to patients who want a less visible, more comfortable alternative to traditional pumps with tubes. By offering a higher-capacity option, Medtrum is targeting patients who previously may not have been well served by 200U devices, Newswire reported.
Sentiment
NeutralNEGATIVENEUTRALPOSITIVE
Publishers
4
Articles
3
Reach
4
A
AnonymousAuthor